The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Incidence of febrile neutropenia in patients with early-stage breast cancer receiving adjuvant FEC-D treatment.
H. Assi
No relevant relationships to disclose
D. Richard
No relevant relationships to disclose
L. Boyle
No relevant relationships to disclose
M. A. Shaikh
No relevant relationships to disclose
S. A. Bourque
No relevant relationships to disclose